To have your clinical trial included in our list, please complete the Clinical Trial Information Form
- Andrea Kelly, MD, MSCE & Michael Rickels, MD, MS - Determination of Beta-Cell Responsiveness to the Incretin Hormones GLP-1 and GIP in Cystic Fibrosis
- Kelly, MD, MSCE & Michael Rickels, MD, MS - Emergence and Progression of Abnormal Glucose Tolerance in Cystic Fibrosis
- Andrea Kelly, MD, MSCE & Michael Rickels, MD, MS- Effects of GLP-1 Agonist Therapy on Insulin Secretion in Adults with Pancreatic Insufficient Cystic Fibrosis and Abnormal Glucose Tolerance: a randomized, open-label, cross-over trial
- Ali Naji, MD & Michael Rickles, MD, MS - A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of VX-880 in Subjects Who Have Type 1 Diabetes Mellitus with Impaired Hypoglycemic Awareness and Severe Hypoglycemia
- Michael Rickels, MD, MS - A phase 3, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of 400 mg twice a day oral ladarixin in patients with new-onset type 1 diabetes and a low residual β-cell function at baseline
- Michael Rickels, MD, MS - Automated Insulin Delivery in Elderly with Type 1 Diabetes (AIDE T1D): A Randomized Cross-over Trial Evaluating Automated Insulin Delivery Technologies on Hypoglycemia and Quality of Life in Elderly Adults with Type 1 Diabetes
- Mark Schutta, MD - Epidemiology of Diabetes Interventions and Complications Study (EDIC STUDY)
- Felix Wehrli, PhD Bone Water and Mineralization Measured by Nuclear Magnetic Resonance